AzTrials
AzTrials

Sensory Integration DisorderNCT05431647

Sensory Integration for Infants With Cortical Visual Impairment

A study testing Sensory integration therapy in people with Sensory Integration Disorder, run by Hacettepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Our study examines the effect of sensory integration training on sensory, motor and oculomotor skills in infants with cortical vision impairment . Read more about this study

Who is it for?
Ages 12 to 18 monthsHealthy volunteers can take part
Conditions the study is for
Sensory Integration Disorder
What is being tested?
Sensory integration therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteTurkey (Türkiye)
Study dates
6 Jan 2021to 5 Jun 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Cerepral palsy
  • Cortical visual impairment
  • 12-18 months

Who cannot join

  • Not participating in treatment regularly

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Occupational Therapy Department

    Ankara, Çankaya, 06530

Other trials in Turkey (Türkiye)

About this study

Official title: The Effectiveness of Sensory Integration Interventions on Motor and Sensory Functions in Infants With Cortical Vision Impairment and Cerebral Palsy: A Single Blind Randomized Controlled Trial

Our study examines the effect of sensory integration training on sensory, motor and oculomotor skills in infants with cortical vision impairment .

Read the detailed description

Cortical vision impairment (CVI) and Cerebral Palsy (CP) lead to decrement in sensory and motor functions of infants. The current study examined the effectiveness of sensory integration interventions on sensory, motor, and oculomotor skills in infants with cortical vision impairment. Thirty-four infants with CVI and CP aged 12-18 months were enrolled to the study. The infants were randomly divided into 2 groups as the control and intervention groups. The intervention group took sensory integration intervention 2 days a week for 8 weeks in addition to conventional physiotherapy two days a week for eight weeks. The control group only received the conventional physiotherapy program 2 days a week for 8 weeks. The duration of the treatment sessions were 45 minutes for both interventions. Before and after the intervention, sensory processing functions were evaluated with the Test of Sensory Functions in Infants (TSFI) and motor functions were evaluated with the Alberta Infant Motor Scale (AIMS).

Being tested
Sensory integration therapy
Keywords
Cerebral Palsy, Cortical Visual Impairment, Sensory Integration, Motor Function, Early Intervention.
Medical subject headings
Cerebral Palsy, Blindness, Cortical

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensory integration therapyOther

    The individuals were divided into two as randomized controlled. Both physiotherapy and sensory integration therapy were applied to the intervention group. Each treatment was applied as 2 sessions per week, 2 days a week for 8 weeks. In the control group, only physiotherapy treatment was applied for 8 weeks, 2 days a week, 2 sessions per week.

Study groups in NCT05431647
Study groupRoleWhat they receive
İntervention group: Physiotherapy and Sensory Integration TherapyActive comparatorPhysiotherapy program 8 weeks 2 days in a week 45 minutes per session Conventional physiotherapy Sensory integration therapy program 8 weeks 2 days in a week 45 minutes per session Sensory integration therapy
Receives: Other: Sensory integration therapy
Control group only PhysiotherapyActive comparatorPhysiotherapy program 8 weeks 2 days in a week 45 minutes per session Conventional physiotherapy
Receives: Other: Sensory integration therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Test of Sensory Functions in Infants (TSFI)

    The TSFI consists of 24 items. It was developed to evaluate sensory processing problems in infants aged 4 to 18 months. The test consists of five subsections and 24 items.

    Measured: 30 minute

  2. Alberta Infant Motor Scale (AIMS)

    The AIMS gives information about the gross motor development of infants whose corrected ages are between 0 and 18 months. In AIMS, the age of infants is calculated as the corrected age. It allows the family and the clinician to obtain information about the infant's current motor development and to compare the motor development before and after treatment.

    Measured: 30 minute

Secondary outcomes (2)
  1. Test of Sensory Functions in Infants (TSFI)

    The TSFI consists of 24 items. It was developed to evaluate sensory processing problems in infants aged 4 to 18 months. The test consists of five subsections and 24 items.

    Measured: 30 minute

  2. Alberta Infant Motor Scale (AIMS)

    The AIMS gives information about the gross motor development of infants whose corrected ages are between 0 and 18 months. In AIMS, the age of infants is calculated as the corrected age. It allows the family and the clinician to obtain information about the infant's current motor development and to compare the motor development before and after treatment.

    Measured: 30 minute

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2022
  2. Study start6 Jan 2021
  3. Primary completion15 Jan 2021
  4. Study completion5 Jun 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05431647
Sponsor's protocol ID
2020-20/494
Status last verified
Jun 2022
First submitted
20 Jun 2022
Last updated
27 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Sensory integration therapy in people with Sensory Integration Disorder, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Test of Sensory Functions in Infants (TSFI) (time frame: 30 minute). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2022; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in